Cardiac pacing has been transformed by miniaturisation: the traditional pocket-and-lead pacemaker now has a leadless alternative that lives entirely inside the heart. The Medtronic Micra line is the most established of these devices, and it is changing what cardiology departments can offer bradycardia patients.
What the official record says
According to Medtronic official product information, the Micra is the company smallest line of pacemakers — leaving no bump under the skin, no chest scar and requiring no lead; it is completely self-contained within the heart and provides pacing therapy without a visible or physical reminder of a medical device. Official model numbers listed include MC2AVR1, MC2VR01, MC1AVR1 and MC1VR01. Patient-selection criteria and clinical specifications must be confirmed from official Medtronic documentation.
Why leadless matters for African cardiology programmes
For patients, the appeal is cosmetic and physical: no surgical pocket and no transvenous lead — the components most associated with conventional pacing complications. For programmes, leadless pacing extends options for patients where pocket complications are a concern.
Programme planning
Hospitals adopting leadless pacing need implantation expertise, catheter-lab capability, device follow-up arrangements and staff training.
How KRIMS helps
KRIMS Meditech Solutions sources cardiac technology from verified original manufacturers such as Medtronic and supports hospitals across Africa with procurement and programme support. To request a quotation for the Micra pacemaker, request a quote through KRIMS.
